VYNE Therapeutics Inc.VYNENASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank60
5Y CAGR-68.8%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
-68.8%/yr
Long-term compound
Percentile
P60
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 13.77% |
| 2024 | 18.16% |
| 2023 | -11.11% |
| 2022 | -48.76% |
| 2021 | -95.57% |
| 2020 | 4638.83% |
| 2019 | -95.84% |
| 2018 | 132.21% |
| 2017 | 579.82% |
| 2016 | 0.00% |